After using Polypoly-ICLC-assisted tumor lysate vaccine to treat patients with low-grade gliomas, the drugs acquired a good efficacy and the number of CD8+ TRM cells increased in TME (NCT02549833). The gene discussed is CD8A; the disease is neoplasm.